Profile: Virbac SA (VIRB.PA)
VIRB.PA on Paris Stock Exchange
170.55EUR
5:50am EDT
170.55EUR
5:50am EDT
Price Change (% chg)
€-0.75 (-0.44%)
€-0.75 (-0.44%)
Prev Close
€171.30
€171.30
Open
€169.80
€169.80
Day's High
€172.00
€172.00
Day's Low
€169.55
€169.55
Volume
453
453
Avg. Vol
6,066
6,066
52-wk High
€189.80
€189.80
52-wk Low
€118.40
€118.40
Virbac SA is a France-based veterinarian pharmaceutical company that specializes in the development and production of vaccines and medicines for domestic animals and livestock. Its production centers are located in France, Australia, the United States, Mexico, Vietnam, Brazil and South Africa. Its development efforts focus mainly on formulating drugs designed to prevent or cure certain animal diseases. Its product portfolio encompasses pet medications such as pest control drugs, vaccines, antibiotics, anesthetics, anti-inflammatory drugs, mouth/dental care products, ophthalmologic and dermatological products intended for dogs, cats, horses, birds and rodents, as well as livestock medications including pest control drugs and antibiotics intended for cattle, sheep, pigs and poultry. It also offers food and electronic identification chips for pets. As of December 31, 2011, it operated through numerous subsidiaries located in Europe, South Korea, Philippines and Thailand, among others.
Company Address
Virbac SA
13e rue LID, BP 27, Carros cedex
CARROS F 06511
P: +334.92087100
F: +334.92087165
Company Web Links
| Name | Compensation |
|---|---|
Marie-Helene Dick |
109,000 |
Eric Maree |
502,707 |
Pierre Pages |
347,925 |
Jeanine Dick |
12,000 |
Michel Garaudet |
235,188 |

